Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       


Target Growth Portfolio, 1st Quarter 2018 Series
Ticker Symbol: FWDTRX

Ticker Company Name Initial
ABMD ABIOMED, Inc. 3.29% $207.80
ALGN Align Technology, Inc. 3.32% 248.90
ALSN Allison Transmission Holdings, Inc. 3.36% 44.75
MO Altria Group, Inc. 3.34% 70.31
ANET Arista Networks, Inc. 3.35% 251.06
BUFF Blue Buffalo Pet Products, Inc. 3.34% 33.14
XEC Cimarex Energy Co. 3.31% 128.24
CGNX Cognex Corporation 3.33% 67.78
DVN Devon Energy Corporation 3.35% 43.25
ECA EnCana Corporation 3.35% 13.31
EXEL Exelixis, Inc. 3.34% 29.30
FCX Freeport-McMoRan Inc. 3.33% 19.81
GPS The Gap, Inc. 3.34% 32.30
HD The Home Depot, Inc. 3.36% 192.04
ILMN Illumina, Inc. 3.41% 227.06
LII Lennox International Inc. 3.39% 214.14
LOW Lowe’s Companies, Inc. 3.36% 93.71
MU Micron Technology, Inc. 3.34% 45.55
MNST Monster Beverage Corporation 3.36% 64.03
NFX Newfield Exploration Company 3.34% 34.80
NVDA NVIDIA Corporation 3.33% 222.00
NVR NVR, Inc. 3.02% 3,624.80
ROST Ross Stores, Inc. 3.32% 81.22
STLD Steel Dynamics, Inc. 3.33% 45.97
TROW T. Rowe Price Group, Inc. 3.30% 109.88
TXN Texas Instruments Incorporated 3.38% 109.64
THO Thor Industries, Inc. 3.33% 153.75
OLED Universal Display Corporation 3.41% 194.85
VST Vistra Energy Corp. 3.33% 18.70
ZTS Zoetis Inc. 3.34% 74.24

* As of the close of business on 1/8/18.
Market values are for reference only and are not indicative of your individual cost basis. Holdings were selected by applying the strategy two business days prior to the Initial Offering Date.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Offering Date 1/10/2018
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 4/9/2019
Cash CUSIP 30305Y195
Reinvestment CUSIP 30305Y203
Fee Accounts Cash CUSIP 30305Y211
Fee Accounts Reinvestment CUSIP 30305Y229

Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 1.35%
Creation & Development Fee:   0.50%
Maximum Sales Charge:   1.85%

The deferred sales charge will be deducted in three monthly installments commencing 4/20/18.

When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge.

Fee/Wrap Accounts
Maximum Sales Charge: 0.50%

The maximum sales charge for investors in fee accounts consists of the creation and development fee. Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges apply to units purchased as an ineligible asset.

The creation and development fee is a charge of $.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10 per unit, the creation and development fee will be less than 0.50%; if the price you pay is less than $10 per unit, the creation and development fee will exceed 0.50%.

In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.

You should consider the portfolio's investment objective, risks, and charges and expenses carefully before investing. Contact your financial advisor or call First Trust Portfolios, L.P. at 1-800-621-1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Risk Considerations:

An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

One of the securities held by the trust is issued by a foreign entity. An investment in a portfolio containing equity securities of foreign issuers is subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting foreign issuers.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

Fund Cusip Information
30305Y195 (Cash)
30305Y203 (Reinvest)
30305Y211 (Cash-Fee)
30305Y229 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA and the Internal Revenue Code. First Trust has no knowledge of and has not been provided any information regarding any investor. Financial advisors must determine whether particular investments are appropriate for their clients. First Trust believes the financial advisor is a fiduciary, is capable of evaluating investment risks independently and is responsible for exercising independent judgment with respect to its retirement plan clients.
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2018 All rights reserved.